Antiviral Drugs Market: Global Industry Analysis, Trends, Market Size & Forecasts up to 2023

1
Antiviral Drugs Market Global Industry Analysis,
Trends, Market Size Forecasts up to 2023
2
The report on Antiviral Drugs Market by drug
type(drugs and generic drugs),
therapeutics(HIV/AIDS therapeutics, hepatitis
(BC) therapeutics, herpes therapeutics,
influenza therapeutics and others), end
user(hospitals, clinics and ambulatory surgical
center) trends analysis and forecasts up to 2023
studies the market sizes, key trends and
opportunities in the main geographies such as
North America, Europe, Asia-Pacific, Rest of the
World. According to the report the Global
Antiviral Drugs Market is projected to grow at a
CAGR between 4.0 to 4.5 in terms of value
over the period of 2017-2023. The growth in the
world market is primarily driven by significant
contribution by North America (Leading region)
region to this market. Get a Sample Request-
https//www.infiniumglobalresearch.com/Reports/Mak
eSampleRequest/765 Market Insights Global
antiviral drugs market has grown moderately over
the past few years, but during the forecast
period this market likely to have healthy gains.
As of 2023, as per the WHO 35.3 Mn people were
infected with HIV globally, hence increased
in viral infection incidences considered as
one of the strong driving force in this market.
Due to which robust RD activities, advanced trea
tments and formulations such as vaccines,
3
combination therapy, and others introduced in the
market. Moreover, Strong research and
development activities have led to introduction
of new drugs with better efficacy and less side
effects thereby contributing significantly in the
global growth. On the other hand, High risk of
failure, higher cost associated with research and
development activities, and stringent government
regulations are the major growth barriers
inhibiting global growth of this
market. Increasing incidences of epidemics in
viral infections such as influenza, respiratory
syncytial virus and others anticipated to provide
massive growth opportunities for this market
over the forecast period. Whereas, High cost
associated with development of new drugs and
usage of natural products will pose as major
challenge in front of this market. Make an
Enquiry- https//www.infiniumglobalresearch.com/
Reports/MakeEnquiryRequest/765 Segments
Covered The report segments the global antiviral
drugs market by drug type, by therapeutics, by
end user, and by region. The market size of each
segment has been provided in terms of value
(USD) and volume (tons). Market segmentation
based on type includes branded drugs and generic
drugs. On the basis of therapeutics global market
has been divided
4
into HIV/AIDS therapeutics, hepatitis (BC)
therapeutics, herpes therapeutics, influenza
therapeutics and others (Pneumonia). Market
segmentation based on end user includes
hospitals, clinics, and ambulatory surgical
center Geographic Coverage and Analysis The
report provides regional analysis covering
geographies such as North America, Europe,
Asia-Pacific, and Rest of the World. In this
section the key trends and market size for each
geography is provided over the period of 2017
2023. With over 30 global market shares in the
market, North America is the largest consumer of
antiviral drugs as of 2015. In which US drives
the North America antiviral drugs market.
Moreover US has large number of HIV infected
population, due to which there is vast demand
for antiviral drugs in this region, and has made
this region largest consumer. Factors including
high level of drug development, sophisticated
healthcare infrastructure, increasing awareness
level, presence of key players in this region
have significantly contributed in the regional
growth of North America. Following North
America, Europe is the second largest market.
Germany, UK, France and Italy are the important
markets in this region. Asia Pacific, however, is
anticipated to provide high potential growth
throughout the forecast period. The region will
emerge with highest CAGR on account of presence
of established generic industry, growing base of
target
5
population, and improving economic stability.
Furthermore, India drives the APAC antiviral
therapeutics market by havning highest cases of
HIV. Companies Profiled The companies covered
in the report include Roche Holding AG, Gilead,
GlaxoSmithKline, Bristol-Myers-Squibb, Abbott
Healthcare, Med Immune/AstraZeneca,
Schering-Plough, Johnson Johnson, Merck Co,
Gilead Sciences, Dr Reddy, and Cipla. Click the
Below Full Report- https//www.infiniumglobalrese
arch.com/healthcare_medical_devices/global_antivir
al_drugs_market Report Highlights The report
provides deep insights on demand forecasts,
market trends and micro and macro indicators. In
addition, this report provides insights on the
factors that are driving and restraining the
demand of antiviral drugs globally as well as
regionally. Moreover, IGR-Growth Matrix analysis
given in the report brings an insight on the
investment areas that existing or new market
players can consider.
6
The report provides insights into the market
using analytical tools such as Porters five
forces analysis and DRO analysis of antiviral
drugs. Moreover, the study highlights current
market trends and provides forecast from 2017 to
2023. We also have highlighted future trends in
the antiviral drugs market that will impact the
demand during the forecast period. Moreover, the
competitive analysis given in each regional
market brings an insight on the market share of
the leading players. Additionally, the analysis
highlights rise and fall in the market shares of
the key players in the market. This report will
help manufacturers, suppliers and distributors of
the antiviral drugs market to understand the
present and future trends in this market and
formulate their strategies accordingly.